India Expands QR Code Traceability for Critical Medicines including Vaccines and Anti-Cancer Drugs

Key Facts

• The Union Health Ministry amended the Drugs Rules, 1945, on June 25, 2026.
• Vaccines, anti-cancer medicines, antimicrobials (including antibiotics), narcotic and psychotropic drugs are now included under Schedule H2.
• Manufacturers are required to print or affix QR codes on the primary packaging or secondary packaging if space is insufficient.
• The QR code stores data such as unique product identification code, generic and brand names, manufacturer name and address, batch number, manufacturing and expiry dates, manufacturing licence number, and details of excipients if applicable.
• The mandate previously applied only to the top 300 pharmaceutical brands but now extends to all medicines in these categories.
• Implementation dates are staggered: July 1, 2027, for vaccines, anti-cancer medicines, narcotic and psychotropic drugs; July 1, 2028, for antimicrobials.

Background & Context

The Drugs Rules, 1945, provide a regulatory framework for drug manufacture, sale, and labeling in India. Schedule H2 pertains to prescription drugs that require special labeling and traceability. QR code-based traceability is a digitally readable system enabling effective tracking and verification of medicines across the supply chain. This amendment expands the scope of the existing QR code-based system to enhance drug safety, curb counterfeit drugs, and combat antimicrobial resistance by monitoring antimicrobial drugs more precisely.

Why This Matters for Exams / Exam Relevance

This regulatory change integrates public health policy with pharmaceutical supply chain management and technology. Competitive exams may test knowledge about the Drugs Rules, 1945, the significance of Schedule H2, the impact of QR code implementation on medicine safety, and national strategies against antimicrobial resistance (AMR). Familiarity with the timeline, affected drug categories, and purpose of these amendments is vital.

Points to Remember

• Notification date: June 25, 2026.
• Expanded Schedule H2 coverage includes all vaccines, anti-cancer medicines, antimicrobials, narcotic and psychotropic drugs.
• QR code implementation effective from July 1, 2027 (vaccines, anti-cancer, narcotic, psychotropic), and July 1, 2028 (antimicrobials).
• QR codes are mandatory on primary packaging or secondary packaging when space is insufficient.
• Purpose of the amendment includes improving medicine traceability, preventing counterfeit products, and supporting AMR containment.
• QR code details include unique identifiers, manufacturer details, batch and license info, manufacturing and expiry dates, and excipients if any.